Amedisys Inc (STU:ADY)
€ 87 0 (0%) Market Cap: 2.90 Bil Enterprise Value: 3.24 Bil PE Ratio: 0 PB Ratio: 2.86 GF Score: 85/100

Amedisys Inc at Barclays Global Healthcare Conference Transcript

Mar 17, 2022 / 12:00PM GMT
Release Date Price: €139
Sarah Elizabeth James
Barclays Bank PLC, Research Division - Research Analyst

Good morning, and thank you all for joining us. I'm Sarah James, emerging health care delivery model and provider analyst at Barclays. And we're really thrilled to have with us here today Amedisys. We've got pretty much the full management team here. We've got Chris Gerard, President and COO; Scott Ginn, EVP and CFO; and Nick Muscato, SVP of Finance. So thank you, guys, all for joining us here.

Scott G. Ginn
Amedisys, Inc. - Executive VP & CFO

Thank you for having us.

Christopher T. Gerard
Amedisys, Inc. - President, COO & Director

Thank you.

Questions & Answers

Sarah Elizabeth James;Christopher T. Gerard
Barclays Bank PLC, Research Division - Research Analyst;Amedisys, Inc. - President, COO & Director

So wanted to open up with some questions on big picture. How do you think about long-term growth developing over the next few years?

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot